Ahlskog JE - Search Results

1

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Uitti RJ, et al. Among authors: ahlskog je. Neurology. 1996 Jun;46(6):1551-6. doi: 10.1212/wnl.46.6.1551. Neurology. 1996. PMID: 8649547

2

Hemimasticatory spasm: clinical and electrophysiologic observations.

Auger RG, Litchy WJ, Cascino TL, Ahlskog JE. Auger RG, et al. Among authors: ahlskog je. Neurology. 1992 Dec;42(12):2263-6. doi: 10.1212/wnl.42.12.2263. Neurology. 1992. PMID: 1461376

3

Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide).

Ahlskog JE, Muenter MD, Bailey PA, Stevens PM. Ahlskog JE, et al. Arch Neurol. 1992 May;49(5):560-8. doi: 10.1001/archneur.1992.00530290152026. Arch Neurol. 1992. PMID: 1580821

4

Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.

Ahlskog JE, Richelson E, Nelson A, Kelly PJ, Okazaki H, Tyce GM, van Heerden JA, Stoddard SL, Carmichael SW. Ahlskog JE, et al. Ann Neurol. 1991 Aug;30(2):185-91. doi: 10.1002/ana.410300210. Ann Neurol. 1991. PMID: 1654766

5

New concepts in the treatment of Parkinson's disease.

Ahlskog JE, Wilkinson JM. Ahlskog JE, et al. Am Fam Physician. 1990 Feb;41(2):574-84. Am Fam Physician. 1990. PMID: 1967895

6

Medical treatment of Parkinson's disease.

Ahlskog JE. Ahlskog JE. Compr Ther. 1989 Mar;15(3):53-9. Compr Ther. 1989. PMID: 2650977 Review. No abstract available.

7

Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.

Ahlskog JE, Tyce GM, Kelly PJ, van Heerden JA, Stoddard SL, Carmichael SW. Ahlskog JE, et al. Exp Neurol. 1989 Aug;105(2):152-61. doi: 10.1016/0014-4886(89)90114-3. Exp Neurol. 1989. PMID: 2753115

8

PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent.

Muenter MD, Ahlskog JE, Bell G, McManis P. Muenter MD, et al. Among authors: ahlskog je. Neurology. 1988 Oct;38(10):1541-5. doi: 10.1212/wnl.38.10.1541. Neurology. 1988. PMID: 2901697

9

Pergolide: long-term use in Parkinson's disease.

Ahlskog JE, Muenter MD. Ahlskog JE, et al. Mayo Clin Proc. 1988 Oct;63(10):979-87. doi: 10.1016/s0025-6196(12)64912-x. Mayo Clin Proc. 1988. PMID: 3050301 Clinical Trial.

10

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Ahlskog JE, et al. Neurology. 1995 Jul;45(7):1340-4. doi: 10.1212/wnl.45.7.1340. Neurology. 1995. PMID: 7617195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters